PA8577701A1 - Polipeptido t20 pegilado - Google Patents

Polipeptido t20 pegilado

Info

Publication number
PA8577701A1
PA8577701A1 PA20038577701A PA8577701A PA8577701A1 PA 8577701 A1 PA8577701 A1 PA 8577701A1 PA 20038577701 A PA20038577701 A PA 20038577701A PA 8577701 A PA8577701 A PA 8577701A PA 8577701 A1 PA8577701 A1 PA 8577701A1
Authority
PA
Panama
Prior art keywords
pegilated
polypeptide
compounds
compositions
polypeptide compounds
Prior art date
Application number
PA20038577701A
Other languages
English (en)
Inventor
Chee-Youb Won
Pascal Sebastian Bailon
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of PA8577701A1 publication Critical patent/PA8577701A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C07K14/08—RNA viruses
    • C07K14/15—Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus human T-cell leukaemia-lymphoma virus
    • C07K14/155—Lentiviridae, e.g. visna-maedi virus, equine infectious virus, FIV, SIV
    • C07K14/16—HIV-1 ; HIV-2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Abstract

SE PROPORCIONAN COMPUESTOS POLIPEPTIDOS T20 PEGILADOS. TAMBIEN SE PROPORCIONAN COMPOSICIONES FARMACEUTICAS QUE CONTIENEN COMPUESTOS POLIPEPTIDOS T20 PEGILADOS, Y PROCESOS DE ELABORACION Y USO DE TALES COMPUESTOS Y COMPOSICIONES.
PA20038577701A 2002-07-24 2003-07-21 Polipeptido t20 pegilado PA8577701A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US39819502P 2002-07-24 2002-07-24

Publications (1)

Publication Number Publication Date
PA8577701A1 true PA8577701A1 (es) 2004-02-07

Family

ID=31495720

Family Applications (1)

Application Number Title Priority Date Filing Date
PA20038577701A PA8577701A1 (es) 2002-07-24 2003-07-21 Polipeptido t20 pegilado

Country Status (24)

Country Link
US (1) US7049415B2 (es)
EP (1) EP1527088B1 (es)
JP (1) JP4381301B2 (es)
KR (1) KR100637981B1 (es)
CN (1) CN100357317C (es)
AR (1) AR040651A1 (es)
AT (1) ATE489401T1 (es)
AU (1) AU2003257467B2 (es)
BR (1) BR0312889A (es)
CA (1) CA2493534C (es)
DE (1) DE60335111D1 (es)
ES (1) ES2354609T3 (es)
GT (1) GT200300155A (es)
HR (1) HRP20050024A2 (es)
IL (2) IL166038A0 (es)
MX (1) MXPA05000797A (es)
NO (1) NO20050066L (es)
PA (1) PA8577701A1 (es)
PE (1) PE20040705A1 (es)
PL (1) PL375254A1 (es)
RU (1) RU2296769C2 (es)
TW (1) TW200416225A (es)
WO (1) WO2004013164A1 (es)
ZA (1) ZA200500258B (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6057287A (en) 1994-01-11 2000-05-02 Dyax Corp. Kallikrein-binding "Kunitz domain" proteins and analogues thereof
DK1531791T3 (da) 2002-06-07 2010-11-01 Dyax Corp Forebyggelse og begrænsning af iskæmi
US7153829B2 (en) 2002-06-07 2006-12-26 Dyax Corp. Kallikrein-inhibitor therapies
EP1663281B1 (en) * 2003-08-29 2013-12-25 Dyax Corp. Poly-pegylated protease inhibitors
EP1663279A4 (en) * 2003-08-29 2009-02-18 Dyax Corp MODIFIED PROTEASE INHIBITORS
WO2005089805A2 (en) * 2004-03-15 2005-09-29 Nektar Therapeutics Al, Corporation Polymer-based compositions and conjugates of hiv entry inhibitors
US7235530B2 (en) 2004-09-27 2007-06-26 Dyax Corporation Kallikrein inhibitors and anti-thrombolytic agents and uses thereof
TWI340142B (en) * 2005-04-08 2011-04-11 Lonza Ag Method of peptide synthesis
CA2696208A1 (en) * 2007-08-21 2009-02-26 Genzyme Corporation Treatment with kallikrein inhibitors
WO2010080833A1 (en) 2009-01-06 2010-07-15 Dyax Corp. Treatment of mucositis with kallikrein inhibitors
RS57870B1 (sr) 2010-01-06 2018-12-31 Dyax Corp Proteini koji vezuju kalikrein plazme
KR102107695B1 (ko) 2011-01-06 2020-05-07 다이액스 코포레이션 혈장 칼리크레인 결합 단백질
BR112016022318A2 (pt) 2014-03-27 2017-10-31 Dyax Corp método, composição farmacêutica para uso no tratamento de doenças de retina e uso de um anticorpo
US20160151511A1 (en) 2014-12-02 2016-06-02 Antriabio, Inc. Proteins and protein conjugates with increased hydrophobicity
BR112018011622A2 (pt) 2015-12-11 2018-11-27 Dyax Corp método para tratar ataque de angioedema hereditário (hae) ou reduzir a taxa de ataque de hae

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US153694A (en) * 1874-08-04 Improvement in clothes-pounders
KR850004274A (ko) * 1983-12-13 1985-07-11 원본미기재 에리트로포이에틴의 제조방법
US5252714A (en) * 1990-11-28 1993-10-12 The University Of Alabama In Huntsville Preparation and use of polyethylene glycol propionaldehyde
US5464933A (en) * 1993-06-07 1995-11-07 Duke University Synthetic peptide inhibitors of HIV transmission
US5795569A (en) * 1994-03-31 1998-08-18 Amgen Inc. Mono-pegylated proteins that stimulate megakaryocyte growth and differentiation
CH690143A5 (de) * 1995-01-27 2000-05-15 Rieter Automotive Int Ag Lambda/4-Schallabsorber.
US5672662A (en) * 1995-07-07 1997-09-30 Shearwater Polymers, Inc. Poly(ethylene glycol) and related polymers monosubstituted with propionic or butanoic acids and functional derivatives thereof for biotechnical applications
US5990237A (en) * 1997-05-21 1999-11-23 Shearwater Polymers, Inc. Poly(ethylene glycol) aldehyde hydrates and related polymers and applications in modifying amines
CN100383158C (zh) * 1998-03-23 2008-04-23 特莱默里斯公司 关于肽合成的方法以及组合物
US6281331B1 (en) * 1998-03-23 2001-08-28 Trimeris, Inc. Methods and compositions for peptide synthesis
WO2000032772A2 (en) * 1998-11-30 2000-06-08 Eli Lilly And Company Erythropoietic compounds
PE20010288A1 (es) * 1999-07-02 2001-03-07 Hoffmann La Roche Derivados de eritropoyetina
KR100488351B1 (ko) * 2001-12-11 2005-05-11 선바이오(주) 신규한 폴리에틸렌글리콜-프로피온알데히드 유도체

Also Published As

Publication number Publication date
IL166038A0 (en) 2006-01-15
NO20050066L (no) 2005-04-22
DE60335111D1 (de) 2011-01-05
JP4381301B2 (ja) 2009-12-09
ATE489401T1 (de) 2010-12-15
CA2493534A1 (en) 2004-02-12
PE20040705A1 (es) 2004-10-14
AU2003257467A1 (en) 2004-02-23
GT200300155A (es) 2004-03-15
MXPA05000797A (es) 2005-04-19
RU2296769C2 (ru) 2007-04-10
AR040651A1 (es) 2005-04-13
BR0312889A (pt) 2005-06-14
US7049415B2 (en) 2006-05-23
ZA200500258B (en) 2006-01-25
KR20050027257A (ko) 2005-03-18
IL166038A (en) 2010-11-30
EP1527088A1 (en) 2005-05-04
AU2003257467B2 (en) 2008-02-28
CN100357317C (zh) 2007-12-26
TW200416225A (en) 2004-09-01
PL375254A1 (en) 2005-11-28
RU2005105577A (ru) 2005-10-27
ES2354609T3 (es) 2011-03-16
EP1527088B1 (en) 2010-11-24
KR100637981B1 (ko) 2006-10-23
JP2006511455A (ja) 2006-04-06
US20040049018A1 (en) 2004-03-11
CN1671736A (zh) 2005-09-21
WO2004013164A1 (en) 2004-02-12
HRP20050024A2 (en) 2006-02-28
CA2493534C (en) 2010-01-26

Similar Documents

Publication Publication Date Title
SE0301700D0 (sv) Novel compounds
PA8577701A1 (es) Polipeptido t20 pegilado
BR0215405A (pt) Composições e processos de uso de collajolie
DE69824029D1 (de) Bicyclische kinase inhibitoren
DK1299348T3 (da) Forbindelser og sammensætninger til levering af aktive midler
TR200200768T2 (tr) Yeni kuinüklidin türevleri ve bunu içeren ilaç bileşimleri
UY28348A1 (es) Compuestos novedosos
NO20050795L (no) Forbindelser, blandinger og fremgangsmater for utnyttelse av samme
BRPI0417717A (pt) composto, composição farmacêutica, e, uso de um composto
YU9404A (sh) Multimerna, usmerena kontrastna sredstva na bazi peptida
IS6658A (is) Ný efnasambönd
NO20022095L (no) Heterocyklisk substituerte pyrazoloner
ATE270557T1 (de) Hochkonzentrierte, lyophilisierte und flüssige faktor-ix formulierungen
CY1108610T1 (el) Πεπτιδια της il-2 και παραγωγα αυτων και χρηση αυτων ως θεραπευτικοι παραγοντες
MXPA06000407A (es) Isomero c cci-779.
SE9802729D0 (sv) Novel Compounds
BRPI0312649A2 (pt) compostos, composições farmacêuticas contendo os mesmos, e processos de uso para os mesmos.
TR199901057T2 (es)
DE69840603D1 (de) Alpha-ketoamidhaltige multikatalytische protease inhibitoren
BRPI0514672A (pt) polipeptìdeos de fusobacterium e métodos de uso
DK1519944T3 (da) Fremgangsmåder til fremstilling af fibrinogen
SE0102716D0 (sv) Novel compounds
DE60327936D1 (de) Modulatoren von ship-1
PA8577601A1 (es) Derivados aldehido de polietilenglicol
ATE497967T1 (de) Interzelluläre kommunikation erleichternden verbindungen und deren medizinischen verwendungen